These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23525272)

  • 21. [Effects of pravastatin, fosinopril and their combination on myocardium TNF-alpha expression and ventricular remodeling after myocardial infarction in rats].
    Wei M; Gu SM; Zhang YY; Wu YH; Wu ZG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):444-7. PubMed ID: 15932706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left Ventricular Unloading After Acute Myocardial Infarction Reduces MMP/JNK Associated Apoptosis and Promotes FAK Cell-Survival Signaling.
    Li T; Wei X; Evans CF; Sanchez PG; Li S; Wu ZJ; Griffith BP
    Ann Thorac Surg; 2016 Dec; 102(6):1919-1924. PubMed ID: 27378553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular dyssynchrony acutely after myocardial infarction predicts left ventricular remodeling.
    Mollema SA; Liem SS; Suffoletto MS; Bleeker GB; van der Hoeven BL; van de Veire NR; Boersma E; Holman ER; van der Wall EE; Schalij MJ; Gorcsan J; Bax JJ
    J Am Coll Cardiol; 2007 Oct; 50(16):1532-40. PubMed ID: 17936151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-Dimensional Speckle Tracking Echocardiography Predict Left Ventricular Remodeling after Acute Myocardial Infarction in Patients with Preserved Ejection Fraction.
    Hsiao JF; Chung CM; Chu CM; Lin YS; Pan KL; Chang ST; Hsu JT
    PLoS One; 2016; 11(12):e0168109. PubMed ID: 28033331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMP induction and inhibition in myocardial infarction.
    Lindsey ML
    Heart Fail Rev; 2004 Jan; 9(1):7-19. PubMed ID: 14739764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.
    Yan AT; Yan RT; Spinale FG; Afzal R; Gunasinghe HR; Arnold M; Demers C; McKelvie RS; Liu PP
    J Card Fail; 2006 Sep; 12(7):514-9. PubMed ID: 16952784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-infarct morphine treatment mitigates left ventricular remodeling and dysfunction in a rat model of ischemia-reperfusion.
    Rajani SF; Imani A; Faghihi M; Izad M; Kardar GA; Salehi Z
    Eur J Pharmacol; 2019 Mar; 847():61-71. PubMed ID: 30684466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angina pectoris prior to myocardial infarction protects against subsequent left ventricular remodeling.
    Solomon SD; Anavekar NS; Greaves S; Rouleau JL; Hennekens C; Pfeffer MA;
    J Am Coll Cardiol; 2004 May; 43(9):1511-4. PubMed ID: 15120803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular remodeling and systolic deterioration in acute myocardial infarction: findings from the Stent-PAMI Study.
    Mattichak SJ; Harjai KJ; Dutcher JR; Boura JA; Stone G; Cox D; Brodie BR; O'Neill WW; Grines CL
    J Interv Cardiol; 2005 Aug; 18(4):255-60. PubMed ID: 16115154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pravastatin suppresses the increase in matrix metalloproteinase-2 levels after acute myocardial infarction.
    Nakaya R; Uzui H; Shimizu H; Nakano A; Mitsuke Y; Yamazaki T; Ueda T; Lee JD
    Int J Cardiol; 2005 Oct; 105(1):67-73. PubMed ID: 16207547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
    Hansson J; Lind L; Hulthe J; Sundström J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction.
    Wagner DR; Delagardelle C; Ernens I; Rouy D; Vaillant M; Beissel J
    J Card Fail; 2006 Feb; 12(1):66-72. PubMed ID: 16500583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction.
    Mukherjee R; Mingoia JT; Bruce JA; Austin JS; Stroud RE; Escobar GP; McClister DM; Allen CM; Alfonso-Jaume MA; Fini ME; Lovett DH; Spinale FG
    Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2216-28. PubMed ID: 16766634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction.
    Kwon JS; Kim YS; Cho AS; Cho HH; Kim JS; Hong MH; Jeong HY; Kang WS; Hwang KK; Bae JW; Jeong MH; Cho MC; Ahn Y
    Life Sci; 2014 Apr; 101(1-2):15-26. PubMed ID: 24560960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation of plasma matrix metalloproteinase-8 levels late after myocardial infarction with left ventricular volumes and ejection fraction.
    Erkol A; Pala S; Oduncu V; Kılıcgedik A; Kızılırmak F; Karabay CY; Güler A; Kırma C
    Turk Kardiyol Dern Ars; 2013 Oct; 41(7):617-24. PubMed ID: 24164993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum MMP-9 activity as a diagnosing marker for the developing heart failure of post MI patients.
    Jong GP; Ma T; Chou P; Chang MH; Wu CH; Lis PC; Lee SD; Liu JY; Kuo WW; Huang CY
    Chin J Physiol; 2006 Apr; 49(2):104-9. PubMed ID: 16830792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling.
    Yarbrough WM; Mukherjee R; Escobar GP; Mingoia JT; Sample JA; Hendrick JW; Dowdy KB; McLean JE; Lowry AS; O'Neill TP; Spinale FG
    Circulation; 2003 Oct; 108(14):1753-9. PubMed ID: 12975256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
    Zhang ZL; Lin JH; Tao RQ
    Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction.
    Hirohata S; Kusachi S; Murakami M; Murakami T; Sano I; Watanabe T; Komatsubara I; Kondo J; Tsuji T
    Heart; 1997 Sep; 78(3):278-84. PubMed ID: 9391291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.